Anandamide-like compound protected against Alzheimer's symptoms in mice via cannabinoid receptors
An anandamide analog called N-linoleyltyrosine improved motor coordination and spatial memory in Alzheimer's model mice, primarily through CB2 receptor-mediated autophagy.
Quick Facts
What This Study Found
N-linoleyltyrosine (NITyr) improved motor coordination and spatial memory in APP/PS1 mice, reduced amyloid-beta levels in the hippocampus, and upregulated autophagy markers. The CB2 receptor antagonist AM630 blocked these effects, suggesting CB2-mediated autophagy as the primary mechanism.
Key Numbers
Reduced Aβ40 and Aβ42 levels in hippocampus; upregulated LC3-II and Beclin-1 autophagy markers; effects blocked by AM630 (CB2 antagonist) and 3-MA (autophagy inhibitor)
How They Did This
Researchers administered NITyr to APP/PS1 transgenic mice (an Alzheimer's disease model) and assessed motor coordination (rotarod test), spatial memory (Morris water maze), locomotor activity (open field test), and neural tissue integrity (HE and Nissl staining). Autophagy inhibitor 3-MA and CB receptor antagonist AM630 were used to clarify mechanisms.
Why This Research Matters
Alzheimer's disease remains one of the most devastating and poorly treated neurodegenerative conditions. Compounds that can leverage the endocannabinoid system to promote autophagy and clear amyloid-beta offer a novel therapeutic angle.
The Bigger Picture
This adds to growing evidence that the CB2 receptor, which does not produce the psychoactive effects associated with CB1, may be a viable target for neurodegenerative disease therapies.
What This Study Doesn't Tell Us
Animal study in transgenic mice; results may not translate to humans. Single compound tested. No long-term follow-up. Dosing and delivery may not be clinically practical.
Questions This Raises
- ?Would NITyr show similar effects in other Alzheimer's models?
- ?Could this compound or similar CB2 agonists enter human clinical trials?
- ?How does NITyr compare to other endocannabinoid-based interventions?
Trust & Context
- Key Stat:
- CB2 receptor-mediated autophagy drove the neuroprotective effects
- Evidence Grade:
- Well-designed animal study with mechanistic dissection, but findings have not been validated in humans.
- Study Age:
- Published in 2021.
- Original Title:
- N-linoleyltyrosine exerts neuroprotective effects in APP/PS1 transgenic mice via cannabinoid receptor-mediated autophagy.
- Published In:
- Journal of pharmacological sciences, 147(4), 315-324 (2021)
- Authors:
- Long, Chun-Mei, Zheng, Qi-Xue, Zhou, Yi, Liu, Yuan-Ting, Gong, Liu-Ping, Zeng, Ying-Chun, Liu, Sha
- Database ID:
- RTHC-03296
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Is this a cannabis-based treatment?
Not exactly. NITyr is a synthetic compound that mimics anandamide, one of the body's natural endocannabinoids. It acts on the same receptors that cannabis compounds target, particularly CB2.
Did it reverse Alzheimer's in mice?
It improved behavioral symptoms and reduced amyloid-beta deposits, but this was an animal model and does not mean the compound would have the same effects in human Alzheimer's disease.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-03296APA
Long, Chun-Mei; Zheng, Qi-Xue; Zhou, Yi; Liu, Yuan-Ting; Gong, Liu-Ping; Zeng, Ying-Chun; Liu, Sha. (2021). N-linoleyltyrosine exerts neuroprotective effects in APP/PS1 transgenic mice via cannabinoid receptor-mediated autophagy.. Journal of pharmacological sciences, 147(4), 315-324. https://doi.org/10.1016/j.jphs.2021.08.008
MLA
Long, Chun-Mei, et al. "N-linoleyltyrosine exerts neuroprotective effects in APP/PS1 transgenic mice via cannabinoid receptor-mediated autophagy.." Journal of pharmacological sciences, 2021. https://doi.org/10.1016/j.jphs.2021.08.008
RethinkTHC
RethinkTHC Research Database. "N-linoleyltyrosine exerts neuroprotective effects in APP/PS1..." RTHC-03296. Retrieved from https://rethinkthc.com/research/long-2021-nlinoleyltyrosine-exerts-neuroprotective-effects
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.